Clinical Trial Update: PROFIT - Prostate Fractionated Irradiation Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial PROFIT evaluating Prostate Fractionated Irradiation for prostate cancer has completed. The update notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED